急性髓细胞白血病诊治进展

来源 :中华医学会第十三次全国白血病·淋巴瘤学术会议 | 被引量 : 0次 | 上传用户:clear0102
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Defining minimal residual disease in AML: which platforms are ready for "prime time"Why detect MRD in AML? Application of assays to detect submicroscopic levels of leukemic cells of potential value:Provide objective methodology to establish remission status.
其他文献
会议
会议
AML
会议
会议
会议
Tamibarotene, (4[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) carbamoyl] benzoic acid),may be the most attractive synthetic retinoid.It is about 10 t
会议
OutlneEpidemiology Founding Diagnostic techniques AML ALL Epidemiology Annual Incidence of Leukemia 2.76/105 Male: 2.98/105, Female: 2.58/105 AML: 1.62/105 ALL:
会议